Morningstar

Aspiriant Risk-Managed Equity Allocation Fund Advisor Shares RMEAX

Morningstar Medalist Rating
Medalist Rating as of | See Aspiriant Investment Hub
  • NAV / 1-Day Return 18.01  /  +0.61 %
  • Total Assets 1.5B
  • Adj. Expense Ratio
    0.950%
  • Expense Ratio 0.290%
  • Distribution Fee Level Average
  • Share Class Type No Load
  • Category Global Large-Stock Blend
  • Investment Style Large Blend
  • Min. Initial Investment 0
  • Status Open
  • TTM Yield 1.40%
  • Turnover 21%

USD | NAV as of Oct 03, 2026 | 1-Day Return as of Oct 03, 2026, 1:34 AM GMT+0

Morningstar’s Analysis RMEAX

Will RMEAX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

  • Process Pillar

    The Process Pillar is our assessment of how sensible, clearly defined, and repeatable RMEAX’s performance objective and investment process is for both security selection and portfolio construction.

  • People Pillar

    The People Pillar is our evaluation of the RMEAX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.

  • Parent Pillar

    The Parent Pillar is our rating of RMEAX’s parent organization’s priorities and whether they’re in line with investors’ interests.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

Aspiriant Risk-Managed Equity Allc Adv holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.

by Morningstar Automated Analysis
Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings RMEAX

More RMEAX Holdings
  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 71.8
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

GMO Quality VI

34.52 487M
—

Schwab Fundamental Emerging MarketsEqETF

7.20 102M
—

RIEF STRATEGIC PARTNERS FUND

6.45 91M
—

Baillie Gifford Emerging Markets Eqs K

5.67 80M
—

GMO Equity Dislocation Invmt A USD Acc

4.32 61M
—

AQR Large Cap Defensive Style R6

3.84 54M
—

Viking Global Equities Lp

3.41 48M
—

JPMorgan Prime Money Market Inst

3.19 45M
Cash and Equivalents

iShares MSCI Global Min Vol Factor ETF

2.84 40M
—

iShares MSCI ACWI ETF

2.39 34M
—

Sponsor Center